← back to vet-ai
Financial analysis · adoption-ready estimate
VetAI: Stop Managing Paperwork. Start Practicing Medicine.
If an entrepreneur "adopted" this product today, here's the realistic math.
Fermi summary
Land 50 vet practices at $250/mo and you're at $150k ARR - but PMS integration friction and conservative buyers make that a 14% shot, so expect to be cash-negative through year 1 before word-of-mouth kicks in.
Market size (TAM)
$67.0M
28k US private veterinary practices × $2,400 avg annual spend on ops-automation add-ons (reminders, intake, discharge comms) layered onto existing PMS systems
Year-1 ARR range
$45k - $480k
midpoint $150k
Investment to production
$30k
Dev: $14k for integrations with Cornerstone + AVImark (the two dominant PMS systems) plus billing and onboarding flow. Marketing: $10k for V
Probability of success
14%
P(reaching mid case in 12 months)
Expected take-home Y1
$-14880
probability-weighted, after investment
Go-to-market motion
Outbound to practice managers and owner-vets via vet Facebook groups and LinkedIn → live Zoom demo showing time-saved on discharge summaries → $200-300/month subscription with 30-day trial to get past the skepticism.
Key risks
- PMS integration depth: Cornerstone and AVImark have closed or janky APIs - without true two-way sync, this is a parallel workflow tool that adds friction instead of removing it, and practices will churn at month 3
- Conservative, time-starved buyers: vet practice owners are veterinarians first, not tech adopters - sales cycles stretch to 6-8 weeks and one bad demo tanks the referral network in a tight-knit local vet community
- IDEXX and Covetrus are both adding AI features to their incumbent PMS products with 2026 roadmaps - the standalone add-on window may be 18 months before the big players absorb the use case
Generated by the Wishdeal Factory financial-analysis agent. Numbers are honest Fermi estimates, not guarantees. Real outcomes depend on the operator. The studio is bullish on the engineering quality, agnostic on the business outcome.